A Narrative Review Vulvovaginal Candidiasis during Pregnancy: A Narrative Review of Prevalence, Risk Factors, and Antibiogram among Pregnant Mothers.

Vulvovaginal candidiasis (VVC) is an opportunistic fungal infection of the female lower genital tract caused by Candida spp. and is responsible for 90% of the cases of infectious vaginitis. VVC during pregnancy remains neglected; however, it poses several complications, leaving this uniquely vulnerable group at risk of mismanagement. This study addressed these urgent gaps by synthesizing global prevalence trends, pregnancy-specific risk dynamics, and emerging resistance patterns. The VVC incidence was the highest in East Africa, with Kenya reporting the highest prevalence at 90.38%, which was slightly higher than that reported in Uganda (73.1%) and the lowest in developed countries (61.1%). C. albicans was the predominant Candida spp. isolated from both regions. VVC was associated with the use of hormonal contraceptives, a history of diabetes mellitus, the use of antibiotics, regular douching, the third trimester, and a multigravida status. In developed countries, most Candida spp. are resistant to nystatin and clotrimazole, and are sensitive to miconazole. In sub-Saharan countries, nystatin, and miconazole have good antifungal activity, and C. albicans has the highest sensitivity to miconazole. In Uganda, clotrimazole resistance was the highest in C. krusei. All Candida spp. presented the lowest resistance to nystatin and miconazole. In conclusion, VVC is highly prevalent in East Africa and lowest in developed countries, with C. albican as the dominant causative agent peaking in the third trimester. The increasing resistance to nystatin and clotrimazole in developed countries, and to nystatin, and miconazole demonstrated good antifungal activity in sub-Saharan countries and Uganda. This resistance pattern demands flexibility in empirical therapy for non-C. Albican.

Vulvovaginal candidiasis, prevalence, pregnancy, antifungal resistance, risk factors, mothers

1. Adogo, L. Y., Julia, K. M., & Joshua, P. D. (2023). Occurrence and Antifungal Susceptibility of Candida Species Isolated from Pregnant Women in a Tertiary Hospital. Lafia Journal of Scientific and Industrial Research, 38–42. https://doi.org/10.62050/ljsir2023.v1n2.230 [Google Scholar] [Crossref]

2. Aguin, T. J., & Sobel, J. D. (2015). Vulvovaginal candidiasis in pregnancy. Current Infectious Disease Reports, 17(6), 462. https://doi.org/10.1007/s11908-015-0462-0 [Google Scholar] [Crossref]

3. Akpaka, P. E., Ashraph, K., Ivey, M. A., Unakal, C., & Kurhade, A. (2022). Epidemiological evaluation of risk factors associated with vaginal candidiasis in a cross section of pregnant women in Trinidad and Tobago. African Journal of Reproductive Health, 26(3), Article 3. https://www.ajrh.info/index.php/ajrh/article/view/3262 [Google Scholar] [Crossref]

4. Ali, M., Edrees, W. H., Al-Shehari, W. A., Xue, G., Al-Hammadi, S., Qasem, E. A., Chaulagain, R. P., & Lal, N. (2024). Antifungal susceptibility pattern of Candida species isolated from pregnant women. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/ 10.3389/ fcimb.2024. 1434677 [Google Scholar] [Crossref]

5. Al-Janabi, A. A. H. S., & Nama, Z. F. (2024). Impact of vulvovaginal candidiasis on parity and number of living children in pregnant and nonpregnant women. Journal of Xiangya Medicine, 9(0), Article 0. https://doi.org/10.21037/jxym-23-36 [Google Scholar] [Crossref]

6. Bitew, A., & Abebaw, Y. (2018). Vulvovaginal candidiasis: Species distribution of Candida and their antifungal susceptibility pattern. BMC Women’s Health, 18(1), 94. https://doi.org/10.1186/s12905-018-0607-z [Google Scholar] [Crossref]

7. CDC. (2024, May 16). Risk Factors for Candidiasis. Candidiasis. https://www.cdc.gov/ candidiasis/ risk-factors/index.html [Google Scholar] [Crossref]

8. de Cássia Orlandi Sardi, J., Silva, D. R., Anibal, P. C., de Campos Baldin, J. J. C. M., Ramalho, S. R., Rosalen, P. L., Macedo, M. L. R., & Hofling, J. F. (2021). Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options. Current Fungal Infection Reports, 15(1), 32–40. https://doi.org/10.1007/s12281-021-00415-9 [Google Scholar] [Crossref]

9. Disha, T., & Haque, F. (2022). Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: A Review. Infectious Diseases in Obstetrics and Gynecology, 2022, 6195712. https:// doi.org/10.1155/2022/6195712 [Google Scholar] [Crossref]

10. editor. (2012, April 27). Yeast Infection During Pregnancy. American Pregnancy Association. https://americanpregnancy.org/healthy-pregnancy/pregnancy-complications/yeast-infections-during-pregnancy/ [Google Scholar] [Crossref]

11. Edrees, W. H., Al-Asbahi, A. A., Al-Shehari, W. A., & Qasem, E. A. (2020). Vulvovaginal Candidiasis Prevalence among Pregnant Women in Different Hospitals in Ibb, Yemen. Universal Journal of Pharmaceutical Research. https://doi.org/10.22270/ujpr.v5i4.431 [Google Scholar] [Crossref]

12. Edziah, F. S., Acheampong, P. R., Tawiah, P. A., Amengor, C. D., Kpene, G. E., Amponsah, G. O., Baffoe, P. A., & Korankye, G. (2024). Vulvovaginal Candidiasis: Knowledge, Practices and Occurrence Among Pregnant Women Receiving Antenatal Care in a Teaching Hospital, Ghana (p. 2024.12.12.24318968). medRxiv. https://doi.org/10.1101/2024.12.12.24318968 [Google Scholar] [Crossref]

13. Ghaddar, N., Roz, A. E., Ghssein, G., & Ibrahim, J.-N. (2019). Emergence of Vulvovaginal Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species Distribution. Infectious Diseases in Obstetrics and Gynecology, 2019, 5016810. https://doi.org/10.1155/ 2019/5016810 [Google Scholar] [Crossref]

14. Gonçalves, B., Ferreira, C., Alves, C. T., Henriques, M., Azeredo, J., & Silva, S. (2016). Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Critical Reviews in Microbiology, 42(6), 905–927. https://doi.org/10.3109/1040841X.2015.1091805 [Google Scholar] [Crossref]

15. Hussen, I., Aliyo, A., Abbai, M. K., & Dedecha, W. (2024). Vaginal candidiasis prevalence, associated factors, and antifungal susceptibility patterns among pregnant women attending antenatal care at bule hora university teaching hospital, Southern Ethiopia. BMC Pregnancy and Childbirth, 24, 619. https://doi.org/10.1186/s12884-024-06844-x [Google Scholar] [Crossref]

16. Jonani, B., Bwire, H. R., Kasule, C. E., & Mboowa, G. (2024). Lack of Candida africana in Ugandan pregnant women: Results from a pilot study using MALDI-ToF. BMC Research Notes, 17(1), 321. https://doi.org/10.1186/s13104-024-06973-8 [Google Scholar] [Crossref]

17. Kamath, P., Pais, M., & Nayak, M. G. (2013). Risk of vaginal candidiasis among pregnant women. [Google Scholar] [Crossref]

18. Kavitha.Y, D., S, D. M., V, D. A., & Babu, D. H. (2018). A study on Vulvovaginal candidiasis among nonpregnant women. Tropical Journal of Pathology and Microbiology, 4(5), Article 5. https://doi.org/10.17511/jopm.2018.i05.05 [Google Scholar] [Crossref]

19. Khan, M., Ahmed, J., Gul, A., Ikram, A., & Lalani, F. K. (2018). Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infection and Drug Resistance, 11, 447–456. https://doi.org/10.2147/IDR.S153116 [Google Scholar] [Crossref]

20. Konadu, D. G., Owusu-Ofori, A., Yidana, Z., Boadu, F., Iddrisu, L. F., Adu-Gyasi, D., Dosoo, D., Awuley, R. L., Owusu-Agyei, S., & Asante, K. P. (2019). Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana. BMC Pregnancy and Childbirth, 19(1), 341. https://doi.org/10.1186/s12884-019-2488-z [Google Scholar] [Crossref]

21. Levina, J., Ocviyanti, D., & Adawiyah, R. (2024). Management of Vulvovaginal Candidiasis in Pregnancy. Indonesian Journal of Obstetrics and Gynecology, 115–121. https://doi.org/10.32771/inajog.v12i2.1990 [Google Scholar] [Crossref]

22. Maftei, N.-M., Arbune, M., Georgescu, C. V., Elisei, A. M., Iancu, A. V., & Tatu, A. L. (2023). Vulvovaginal Candidiasis in Pregnancy—Between Sensitivity and Resistance to Antimycotics. Journal of Xenobiotics, 13(3), Article 3. https://doi.org/10.3390/jox13030023 [Google Scholar] [Crossref]

23. Messina, A., Mariani, A., Brandolisio, R., Tavella, E., Germano, C., Lipari, G., Leo, L., Masturzo, B., & Manzoni, P. (2024). Candidiasis in Pregnancy: Relevant Aspects of the Pathology for the Mother and the Fetus and Therapeutic Strategies. Tropical Medicine and Infectious Disease, 9(5), Article 5. https://doi.org/10.3390/tropicalmed9050114 [Google Scholar] [Crossref]

24. Michael, O. I., Gabriel, I. M., Olayinka, O. O., Matthew, A. A., & Olajide, A. A. (2022). Prevalence of vulvo-vaginal candidiasis among women attending clinics in selected Hospitals in Oyo State, Southwest, Nigeria. Journal of Public Health and Epidemiology, 14(1), 45–52. https://doi.org/10.5897/JPHE2021.1303 [Google Scholar] [Crossref]

25. Mohamed, A. O., Mohamed, M. S., Mallhi, T. H., Hussain, M. A., Jalloh, M. A., Omar, K. A., Alhaj, M. O., & Ali, A. A. M. M. (2022). Prevalence of vulvovaginal candidiasis among pregnant women in Africa: A systematic review and meta-analysis. The Journal of Infection in Developing Countries, 16(08), Article 08. https://doi.org/10.3855/jidc.15536 [Google Scholar] [Crossref]

26. Mugisha, E. (2013). Species and antifungal susceptibility of Candida causing Vulvovaginal candidiasis among pregnant mothers attending the antenatal clinic at Mulago National Referral Hospital [Thesis, Makerere University]. http://makir.mak.ac.ug/handle/10570/3021 [Google Scholar] [Crossref]

27. Mukasa, K. J., Herbert, I., Daniel, A., Sserunkuma, K. L., Joel, B., & Frederick, B. (2015). Antifungal Susceptibility Patterns of Vulvovaginal Candida species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda. British Microbiology Research Journal, 5(4), 322–331. https://doi.org/10.9734/BMRJ/2015/13804 [Google Scholar] [Crossref]

28. Mulinganya, M. G., De Keyser, K., Mongane, I. J., Kampara, M. F., De Vulder, A., Boelens, J., Duyvejonck, H., Hendwa, E., Kujirakwinja, B. Y., Bisimwa, B. G., Rodriguez, A., Vaneechoutte, M., Callens, S., & Cools, P. (2024). Second trimester vaginal Candida colonization among pregnant women attending antenatal care in Bukavu, Democratic Republic of the Congo: Prevalence, clinical correlates, risk factors and pregnancy outcomes. Frontiers in Global Women’s Health, 5. https://doi.org/10.3389/fgwh.2024.1339821 [Google Scholar] [Crossref]

29. Mushi, M. F., Mmole, A., & Mshana, S. E. (2019). Candida vaginitis among symptomatic pregnant women attending antenatal clinics in Mwanza, Tanzania. BMC Research Notes, 12(1), 775. https:// doi.org/10.1186/s13104-019-4793-z [Google Scholar] [Crossref]

30. Musinguzi, B., J. Sande, O., Mboowa, G., Baguma, A., Itabangi, H., & Achan, B. (2023). Laboratory Diagnosis of Candidiasis. In T. Askun (Ed.), Candida and Candidiasis. IntechOpen. https:// doi.org/10.5772/intechopen.106359 [Google Scholar] [Crossref]

31. Nadia, N. A. C. (2023). Prevalence and Antifungal Resistance Profile of Vulvovaginal Candidiasis Infections in Pregnant Women in Maroua, Far North Region of Cameroon. International Archives of Medical Microbiology, 5(1), 018. https://doi.org/10.23937/2643-4008/1710018 [Google Scholar] [Crossref]

32. Nalumbejja, L. H., & Wolinga, S. (2024). Prevalence and Associated Factors Of Vaginal Candidiasis Among Pregnant Women Attending Antenatal Clinic. A Cross-Sectional Study At Jinja Regional Referral Hospital, Jinja City. SJ Gynecology and Obstetrics Africa, 1(5), Article 5. https://doi.org/10.51168/b4184j61 [Google Scholar] [Crossref]

33. Nelson, M., Wanjiru, W., & Margaret, M. W. (2013). Prevalence of Vaginal Candidiasis and Determination of the Occurrence of Candida Species in Pregnant Women Attending the Antenatal Clinic of Thika District Hospital, Kenya. Open Journal of Medical Microbiology, 3(4), Article 4. https://doi.org/10.4236/ojmm.2013.34040 [Google Scholar] [Crossref]

34. Noumedem Anangmo Christelle, N., Nenba Daga, A., Yamssi, C., Simeni Njonnou Sylvain, R., Djeussi Doriane, E., Lemogo Giresse, N., Gamago Nkadeu, G.-A., Ngouyamsa Nsapkain Aboubakar, S., & Kenfack, B. (2023). Prevalence and Antifungal Resistance Profile of Vulvovaginal Candidiasis Infections in Pregnant Women in Maroua, Far North Region of Cameroon. International Archives of Medical Microbiology, 5(1). https://doi.org/10.23937/2643-4008/1710018 [Google Scholar] [Crossref]

35. Nurat, A. A., Babalola, G. O., Shittu, M. O., Tijani, M. A., & Adekola, S. A. (2015). Detection and Epidemiology of Vulvovaginal Candidiasis among Asymptomatic Pregnant Women Attending a Tertiary Hospital in Ogbomoso, Nigeria. International Journal of Biomedical Research, 6(7), 518. https://doi.org/10.7439/ijbr.v6i7.2242 [Google Scholar] [Crossref]

36. Ohale, O. J., Wemedo, S. A., & Akani, N. P. (2022). Prevalence of Candidiasis among Pregnant and Non-Pregnant Women in Eleme and Okrika Local Government Areas of Rivers State. South Asian Journal of Research in Microbiology, 11–17. https://doi.org/10.9734/sajrm/2022/v14i2269 [Google Scholar] [Crossref]

37. Olowe, O. A., Makanjuola, O. B., Olowe, R., & Adekanle, D. A. (2014). Prevalence of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis among pregnant women receiving antenatal care in Southwestern Nigeria. European Journal of Microbiology & Immunology, 4(4), 193–197. https://doi.org/10.1556/EUJMI-D-14-00027 [Google Scholar] [Crossref]

38. Rasti, S., Asadi, M. A., Taghriri, A., Behrashi, M., & Mousavie, G. (2014). Vaginal Candidiasis Complications on Pregnant Women. Jundishapur Journal of Microbiology, 7(2), Article 2. https://doi.org/10.5812/jjm.10078 [Google Scholar] [Crossref]

39. Roy, M., Majumdar, T., & Ray, J. (2024). Vulvovaginal candidiasis in pregnant women attending a tertiary care center in North-Eastern India. Indian Journal of Medical Microbiology, 52, 100738. https://doi.org/10.1016/j.ijmmb.2024.100738 [Google Scholar] [Crossref]

40. Sangaré, I., Sirima, C., Bamba, S., Zida, A., Cissé, M., Bazié, W. W., Sanou, S., Dao, B., Menan, H., & Guiguemdé, R. T. (2018). Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. Journal de Mycologie Médicale, 28(1), 186–192. https://doi.org/10.1016/j.mycmed.2017.08.006 [Google Scholar] [Crossref]

41. Sule-Odu, A. O., Akadri, A. A., Oluwole, A. A., Osinupebi, O. A., & Andu, B. A. (n.d.). Vaginal Candida infection in pregnancy and its implications for fetal well-being. [Google Scholar] [Crossref]

42. Sutaria, P., Cholera, M., & Donga, S. B. (2019). A prevalence study of vaginal candidiasis among pregnant women. International Journal of Advances in Medicine, 6(3), 922–926. https://doi.org/10.18203/2349-3933.ijam20192265 [Google Scholar] [Crossref]

43. Tasneem, U., Siddiqui, M. T., Faryal, R., & Shah, A. A. (2017). Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan. JPMA. The Journal of the Pakistan Medical Association, 67(7), 986–991. [Google Scholar] [Crossref]

44. Tsega, A., & Mekonnen, F. (2019). Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest Ethiopia. BMC Pregnancy and Childbirth, 19(1), 527. https://doi.org/10.1186/s12884-019-2494-1 [Google Scholar] [Crossref]

45. VVC in pregnancy. (2022, October 11). Contemporary OB/GYN. https://www. contemporaryo bgyn. net/view/vvc-in-pregnancy [Google Scholar] [Crossref]

46. Wang, H., Xu, Y.-C., & Hsueh, P.-R. (2016). Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future Microbiology, 11, 1461–1477. https://doi.org/10.2217/fmb-2016-0099 [Google Scholar] [Crossref]

47. Zvinavashe, D. M. M. M. M. M. (2021). Prevalence of vaginal candidiasis and associated factors in pregnant women with diabetes. African Journal of Midwifery and Women’s Health. https://doi.org/ 10.12968/ajmw.2020.0050 [Google Scholar] [Crossref]

• Measuring Waste of Patient Time in Health Care at Non-Digitized Hospital: An Observational Study in Bangabandhu Sheikh Mujib Medical University, Bangladesh
• Reaffirming Clinical Confidence in Atorvastatin Therapy: A Digital Outreach Case Study from Tamil Nadu, India
• Clinical Manifestations and Therapeutic Response in a Patient with Hypothyroidism: A Case Report
• Eranda (Ricinus Communis) In Gridhrasi (Sciatica): Classical Rationale, Pharmacology and Clinical Evidence- A Narrative Literature Review
• Magnetotherapy in Pain Management: Mechanisms, Clinical Applications, and Future Perspectives – A Review